Ortho Clinical Diagnostics Holdings plc IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Ortho Clinical Diagnostics Holdings plc | OCDX - NASDAQ |
$20.00-$23.00 | $17.00 | $15.50 | 76 million | 1/28/2021 |
| J.P. Morgan, BofA Securities, Goldman Sachs, Barclays, Morgan Stanley, Citigroup, Credit Suisse, UBS Investment Bank, Evercore ISI, Piper Sandler | ||||||
Co-Manager(s): ING, Macquarie Capital, , Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez & Co., Siebert Williams Shank | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-01-04 Terms Added 2021-01-19 | ||||||
Ortho Clinical Diagnostics Holdings plc Quote & Chart - Click for current quote - OCDX
IPO Boutique aggregates information on public companies and private companies, such as "OCDX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Ortho Clinical Diagnostics Holdings plc (adapted from Ortho Clinical Diagnostics Holdings plc prospectus):
They are a pure-play in vitro diagnostics (“IVDâ€) business driven by our credo, “Because Every Test is A Life."
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a pure-play in vitro diagnostics (“IVDâ€) business driven by our credo, “Because Every Test is A Life."
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "OCDX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.